This week, Jonathan Sackier is joined by Sarah Blagden, a pioneer of experimental oncology research, and CEO of RNA Guardian Ltd, a biotechnology company dedicated to identifying early cancer biomarkers.
Timestamps:
(00:00)-Introduction
(01:30)-Recent reads and tweets
(04:57)-Tweets and cancer acceptance
(07:36)-Sarah's journey into oncology
(09:33)-Exploring new drugs and trials
(11:48)-Global experiences and improving the clinical trial environment
(14:28)-Genetics, research, and oncology
(17:27)-Dysregulation of mRNA translation cancer
(18:36)-The future of prevention
(22:33)-Use of metformin
(26:36)-Join us for more next time!